Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission
Pharmacology Biochemistry and Behavior · 2024-12 · 245 · 173879
DOI: 10.1016/j.pbb.2024.173879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2024-12. Verfasst von João F C Pedrazzi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. Elect…. Hauptthemen laut MEDLINE: Cannabidiol, TRPV Cation Channels, Receptor, Serotonin, 5-HT1A, Prepulse Inhibition. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Individuals with schizophrenia (SCZ) often present sensorimotor gating impairments that can be investigated by the prepulse inhibition test (PPI). PPI disruption can be mimicked experimentally with psychostimulants such as amphetamine and attenuated/reversed by antipsychotics. Cannabidiol (CBD), the main non-psychotomimetic component of the Cannabis sativa plant, produces antipsychotic-like effects in clinical and preclinical studies. CBD can interact with many pharmacological targets, but the mechanisms involved in its antipsychotic activity are unclear. Using amphetamine-induced PPI disruption in mice, we investigated the involvement of four CBD potential pharmacological targets (CB1, CB2 TRPV1, and 5-HT1A receptors) in its antipsychotic properties. CBD effects were blocked by the TRPV1 antagonist capsazepine and, to a greater extent, by the 5-HT1A receptor antagonist WAY100635. No effect was observed with the CB1 (AM251) or CB2 (AM630) receptor antagonists. These results corroborate findings showing the antipsychotic effects of CBD in the PPI model and indicate that they involve the participation of TRPV1 and 5-HT1A receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: joaofranciscopedrazzi@usp.br.
- Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
- Department of Basic and Oral Biology, School of Dentistry of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
- Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
- Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
- Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil; Department of Physiology, School of Medicine of Ribeirão Preto, University…
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Pedrazzi, J. F. C., Silva-Amaral, D., Issy, A. C., Gomes, F. V., Crippa, J. A., Guimarães, F. S., & Del Bel, E. (2024). Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission. Pharmacology Biochemistry and Behavior, 245, 173879. https://doi.org/10.1016/j.pbb.2024.173879
Vancouver
Pedrazzi JFC, Silva-Amaral D, Issy AC, Gomes FV, Crippa JA, Guimarães FS, et al. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission. Pharmacology Biochemistry and Behavior. 2024;245:173879. doi:10.1016/j.pbb.2024.173879
BibTeX
@article{Pedrazzi2024,
author = {Pedrazzi, João F C and Silva-Amaral, Danyelle and Issy, Ana C and Gomes, Felipe V and Crippa, José A and Guimarães, Francisco S and Del Bel, Elaine},
title = {Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission},
journal = {Pharmacology Biochemistry and Behavior},
year = {2024},
volume = {245},
pages = {173879},
doi = {10.1016/j.pbb.2024.173879}
}
EUVIMED